Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 24 , ISSUE 8 ( August, 2020 ) > List of Articles


Staphylococcous epidermidis, Staphylococcous schleiferi Infections: Are CoNS Cons?

Betsy Abraham, Antara Gokhale, Jalila Mohsin, Sadanandan Prakash

Citation Information : Abraham B, Gokhale A, Mohsin J, Prakash S. Staphylococcous epidermidis, Staphylococcous schleiferi Infections: Are CoNS Cons?. Indian J Crit Care Med 2020; 24 (8):716-718.

DOI: 10.5005/jp-journals-10071-23523

License: CC BY-NC 4.0

Published Online: 11-12-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Coagulase-negative Staphylococcus (CoNS) represents one of the major nosocomial pathogen in multimorbid, immunosuppressed patients, especially with device-associated infections, often presenting with a diagnostic dilemma and aggressive antibiotic resistance. We report a case of a healthy young man with no comorbidities who succumbed to an extensive abdominal infection with Staphylococcus epidermidis and Staphylococcus schleiferi after an uneventful diagnostic procedure, despite aggressive antibiotic therapy and surgical source control. Early identification, diagnosis, and aggressive management of CoNS species is warranted depending on clinical scenario and should not be viewed as mere skin contaminants or physiological colonization.

  1. Becker K, Heilmann C, Peters G. Coagulase negative Staphylococci. Clin Microbiol Rev 2014;27(4):870–926. DOI: 10.1128/CMR. 00109-13.
  2. Swe T, Naing AT, Baqui AAMA, Khillan R. Methicillin-resistant Staphylococcus schleiferi subspecies coagulans infection in a patient with hepatocellular carcinoma. J Investig Med High Impact Case Rep 2016;4((3):2324709616671148. DOI: 10.1177/2324709616671148.
  3. Davis MF, Cain CL, Brazil AM, Rankin SC. Two coagulase-negative Staphylococci emerging as potential zoonotic pathogens: wolves in sheep's clothing? Front Microbiol 2013;4:123. DOI: 10.3389/fmicb.2013.00123.
  4. Gracia-Vazquez E, Fernandez-Rufete A, Hernandez-Torres A, Canteras M. When is coagulase-negative Staphylococcus bacteraemia clinically significant? Scand J Infect Dis 2013;45(9):664–671. DOI: 10.3109/00365548.2013.797599.
  5. Salih L, Tevell S, Månsson E, Nilsdotter-Augustinsson A, Hellmark B, Söderquist B. Staphylococcus epidermidis isolates from nares and prosthetic joint infections are mupirocin susceptible. J Bone Jt Infect 2018;3(1):1–4. DOI: 10.7150/jbji.22459.
  6. Jindal A, Shivpuri D, Sood S. Staphylococcus schleiferi meningitis in a child. Pediatr Infect Dis J 2015;34(3):329. DOI: 10.1097/INF.0000000000000561.
  7. Thawabii M, Jerome M, Slim J, Shamoon F, Boghossian J. Pericrdial effusion and sepsis caused by Staphylococcus schleiferi. J Infect Public Health 2015;8(4):392–393. DOI: 10.1016/j.jiph.2015.01.006.
  8. John Jr JF, Davidson RJ, Low DE. Staphylococcus epidermidis and other coagulase-negative Staphylococci. Infect Dis
  9. Archer GL, Climo MW. Antimicrobial susceptibility of coagulase negative Staphylococci. Antimicrb Agents Chemther 1994;38(10):2231–2237. DOI: 10.1128/AAC.38.10.2231.
  10. Deresinski S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2009;49(7): 1072–1079.
  11. Therapeutic Monitoring of Vancomycin in Adult Patients: A Consensus Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. ASHP Therapeutic Position Statements.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.